CX3CL1 and lobular neoplasia: Similarly, treatment targeting fractalkine (FKN), a chemokine (C-X3-C motif) ligand 1 known to be involved in the disease progression of LN, also improved renal function and alleviated tubule-interstitial fibrosis.